Retispec’s AI-driven retinal scan was featured in Global News. The feature showcased an initiative led by the Davos Alzheimer’s Collaborative to assess the feasibility of utilizing RetiSpec’s AI technology in community-based settings for Alzheimer’s disease screening.
Retispec is an OBIO® member, an alumnus of the BDSP™, CAAP®, H2BB™, HealthMINT™ and WiHI programs and presented at the OBIO® Investment Summit.